Latest news with #You'llBeBack
Daily Mirror
22-05-2025
- Health
- Daily Mirror
Arnold Schwarzenegger's vital step for full health past your 50s
The 77-year-old assured you don't need to stick to his rigorous routine to age healthily "If you rest, you rust" declared Arnold Schwarzenegger, who at 77 is sharing the best thing he did in his 50s to maintain health while ageing. Speaking at the CNBC CEO Council Summit in Arizona, the actor emphasised the importance of staying active: "It is extremely important to not stop moving when you're 50 or 60 just because of joint problems. "If you stop movement, then this is the first step to death. If you rest, you rust." He stressed that continuing to move is key to healthy ageing, particularly in one's 50s and 60s. The intensity of the activity isn't the focus, though, as Schwarzenegger assured fans don't need to be taking on his personal routine. The iconic Terminator actor suggested: "Do something. It doesn't matter to me if you play tennis, if you go skiing, if you play soccer, or if you lift do something." Arnold's advice is testament to his new role as Chief Movement Officer for Zimmer Biomet, a position he accepted last year. Ever since, he's been using his platform to help people overcome their fear of medical technology which is holding them back from exercising in later life. Despite his portrayals of indestructible characters on the big screen, Schwarzenegger has weathered several serious health challenges. He has undergone two open-heart surgeries to replace parts of his heart and just last year was fitted with a pacemaker due to a genetic heart condition. He's also undergone a hip replacement, which he's turned into a positive message with his ' You'll Be Back ' campaign. He commented: "I want to let people know and give them the courage to get those things fixed and continue moving. Don't let anything get in the way. Exercise, exercise, exercise." The campaign aims to motivate people to stop avoiding treatment, re-engage with physical activity, and enhance their overall health as they grow older. This is especially pertinent for the one in four Americans who suffer from knee pain. According to CNBC, the Austrian celebrity maintains a daily fitness regimen that includes an hour of cycling and 45 minutes of weight training. His extensive gym experience has led to some insightful reflections. He recalled hearing many people complaining about having to skip exercises or adjust their routines as they were told they'd need procedures like shoulder replacements. However, they were afraid of the surgery and opted to let their exercise suffer instead o getting treatment. The ex-governor stressed that surgery should not be the first solution for joint issues. However, he pointed out that many are unaware of the remarkable technological advancements at their disposal. Reflecting on his own hip surgery, he remembered: "When I did it, I had to stay in the hospital for days and had months of therapy." In comparison, he said current technologies can enable patients to "walk out" after the operation.
Yahoo
19-05-2025
- Business
- Yahoo
ZBH Stock to Gain From Buyouts and Innovations Amid Macro Issues
Zimmer Biomet's ZBH strategic priorities, new product launches and focus on international expansion bolster our confidence in this stock. Yet, the difficult macroeconomic situation and FX issues are concerning. The stock carries a Zacks Rank #3 (Hold). Despite challenging market conditions in the form of pricing pressure, the last few quarters witnessed gradual stability in the global musculoskeletal market with better-than-expected sales growth in certain geographies, banking on improved procedural volume. This was driven by favorable demographics and growing utilization of musculoskeletal healthcare in emerging markets and under-penetrated developed markets. The focused execution of the company's global sales teams amid a stable global musculoskeletal market also helped accelerate global sales for Persona, the personalized knee line with this, in the first quarter of 2025, the company witnessed strong growth driven by continued procedure growth, strong execution, and solid momentum with the new innovation. The company saw another positive quarter of year-over-year momentum in large joints, with the overall global Knees, Hips and S.E.T. business growing 1.9%, 2.4% and 4.9%, respectively, at a constant exchange rate. Zimmer Biomet is pursuing a disciplined, four-pillar expansion strategy to achieve a 5% weighted average market growth rate by 2027. First, the company is boosting patient awareness through its 'You'll Be Back' campaign, fronted by chief movement officer Arnold Schwarzenegger. It partners with global medical societies and ramps up digital outreach to encourage the 95% of osteoarthritis sufferers who never seek care. Second, Zimmer Biomet is tackling safety. New iodine surface-treated hip implants, which have debuted in Japan and are slated for launch in the United States, aim to curb periprosthetic joint infections that can carry a higher mortality risk than certain Zimmer Biomet is improving efficiency through smart implants, CT-optional ROSA Robotics, and AI-powered OrthoGrid—streamlining workflows, cutting costs, and boosting surgical capacity. Finally, Zimmer Biomet is elevating outcomes. The newly approved Oxford Partial Cementless Knee shows 93% 10-year survivorship versus 90% for cemented versions in 15,000 UK patients. Zimmer Biomet Holdings, Inc. price | Zimmer Biomet Holdings, Inc. Quote Selective acquisitions remain part of the strategy, backed by solid integration capabilities and a strong balance sheet. In this regard, Zimmer Biomet completed its acquisition of Paragon 28 in April, expanding its presence in the foot and ankle market. The deal is expected to add 270 basis points to Zimmer Biomet's sales growth in 2025. Over the past three months, shares of ZBH have declined 6.3% against the industry's 1.5% gain. With the company consistently focusing on strategic market expansion and new product launches, we expect the stock to regain momentum in the coming days. The ongoing industry-wide trend of staffing shortages and supply chain-related hazards is denting growth for Zimmer Biomet. Deteriorating international trade and geopolitical complications lead to a tough situation related to raw material and labor costs, as well as freight charges. Added to this, high policy rates to fight inflation, along with the gradual withdrawal of fiscal policies amid high debt, continue to dent economic growth, impacting the overall market situation for Zimmer Biomet. Within the Hip category, headwinds in Russia are disproportionately impacting the outside U.S. business. Further, within the S.E.T. category, Zimmer Biomet is facing challenges in the form of reimbursement headwinds, particularly in the Restorative Therapies business. Concerning the ongoing tariff issue, Zimmer Biomet expects a $60–$80 million impact on 2025 operating profit, mainly in the second half, factoring in mitigation efforts and anticipated European reciprocal tariffs. Combined with the Paragon 28 acquisition, this is expected to reduce full-year adjusted operating margins by 100–150 basis points versus 2024. Our model projects a 7.7% and 6.6% increase in the company's cost of product sold and selling, general and administrative expenses for 2025. A substantial portion of Zimmer Biomet's foreign revenues is generated in Europe and Japan. In recent times, significant increases in the value of the U.S. dollar relative to the euro, the Japanese yen, the Swiss Franc, or other currencies have accordingly had an adverse effect on the company's results of operations. In the first quarter of 2025, Zimmer Biomet's net sales were affected by 1.2% from changes in foreign exchange rates. Some better-ranked stocks in the broader medical space include Hims & Hers Health HIMS, Boston Scientific BSX and Cardinal Health CAH. Each of these carries a Zacks Rank #2 (Buy) at present. You can see the complete list of today's Zacks #1 Rank (Strong Buy) stocks here. Estimates for Hims & Hers Health's 2025 earnings per share have jumped 21.2% to 63 cents in the past 30 days. Shares of the company have surged 247.6% in the past year compared with the industry's 19.9% growth. Its earnings yield of 1.1% compares comfortably with the industry's -9.7% yield. HIMS' earnings surpassed estimates in two of the trailing four quarters, matched in one and missed on another occasion, the average surprise being 19.6%. Boston Scientific shares have rallied 40.7% in the past year. Estimates for the company's 2025 earnings per share have jumped 2.1% to $2.91 in the past 30 days. BSX's earnings beat estimates in each of the trailing four quarters, the average surprise being 8.8%. In the last reported quarter, it posted an earnings surprise of 11.9%. Estimates for Cardinal Health's fiscal 2025 earnings per share have increased 2% to $8.09 in the past 30 days. Shares of the company have jumped 56.4% in the past year against the industry's 0.8% fall. CAH's earnings surpassed estimates in each of the trailing four quarters, the average surprise being 910.3%. In the last reported quarter, it delivered an earnings surprise of 9.3%. Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Boston Scientific Corporation (BSX) : Free Stock Analysis Report Cardinal Health, Inc. (CAH) : Free Stock Analysis Report Zimmer Biomet Holdings, Inc. (ZBH) : Free Stock Analysis Report Hims & Hers Health, Inc. (HIMS) : Free Stock Analysis Report This article originally published on Zacks Investment Research ( Zacks Investment Research Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
NBC News
14-04-2025
- Entertainment
- NBC News
Leslie Odom Jr. announces return to ‘Hamilton' on Broadway
It seems like King George III was right when he sang 'You'll Be Back': Leslie Odom Jr. will be returning to the Broadway stage to reprise his role of Aaron Burr in 'Hamilton,' he exclusively announced live on "TODAY" on Monday. Odom — who won a Tony for best leading actor in a musical in 2016 for his portrayal of Aaron Burr, as well as a Grammy for his original Broadway cast recording in 2015 — will have a limited run as the character from Sept. 9 through Nov. 23, 2025. Odom's announcement of his return comes as 'Hamilton' celebrates its 10-year anniversary on Broadway. 'Returning to 'Hamilton' is a deeply meaningful homecoming,' Odom said in a press release. 'I'm so grateful for the chance to step back into the room — especially during this anniversary moment and to revisit this brilliant piece that forever changed my life and the lives of so many.' Odom first played Burr in the off-Broadway 'Hamilton' production and joined the original cast when the show hit Broadway in August 2015. He left the show in July 2016 at the same time fellow stars Phillipa Soo and Lin-Manuel Miranda, who's also the show's creator. This will be the first time he is reprising the role on Broadway. He will take the stage at Broadway's Richard Rodgers Theatre, where 'Hamilton' has been since its Broadway debut. Odom grew particular fame from the song 'The Room Where It Happens,' which allows insight into his character's thirst for knowledge and showcases his vocal prowess. 'When I saw Leslie perform 'The Room Where It Happens' at the first act two workshop of 'Hamilton,' I knew I was witnessing a historic moment,' said Jeffrey Seller, the lead producer of 'Hamilton,' in the press release. 'How lucky we are that Leslie is returning to Hamilton and bringing his indelible Burr back to Broadway.' Since starring in 'Hamilton,' Odom has explored film, TV and other musicals, featuring in works like 'Glass Onion: A Knives Out Mystery,' 'Harriet,' 'Abbott Elementary' and making his Broadway return in the revival of 'Purlie Victorious: A Non-Confederate Romp Through the Cotton Patch.' He also released five studio albums, wrote a memoir called 'Failing Up' and co-authored a children's book with his wife called 'I Love You More Than You'll Ever Know.'
Yahoo
26-02-2025
- Health
- Yahoo
Zimmer Biomet Launches You'll Be Back Campaign with Chief Movement Officer Arnold Schwarzenegger
Schwarzenegger Invites People Living with Joint Pain to Join New Online Community, Share Their Stories and Connect with a Qualified Physician WARSAW, Ind., Feb. 26, 2025 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader, today announced the launch of the You'll Be Back campaign with the Company's Chief Movement Officer, Arnold Schwarzenegger. The goal of the You'll Be Back campaign is to provide the millions of people living with joint pain an online community that empowers them with resources to make informed choices about their mobility. People living with limited mobility due to hip, knee, shoulder or other joint pain, are invited to share their story with Schwarzenegger as part of this launch. Experience the full interactive Multichannel News Release here: "Throughout my decades-long fitness crusade, I have seen the power in building community. You'll Be Back aims to bring together people who are struggling with their mobility and inspire change and action," shared Schwarzenegger, Chief Movement Officer at Zimmer Biomet, global wellness icon and founder of the daily newsletter, "Arnold's Pump Club." "People want to be successful, but fear, uncertainty and lack of vision can get in their way. Whether you want to play on the floor with your grandkids like I do, get up out of the chair pain-free or train for your next 5K race, life is too short to let pain stop you from doing what you love! I want to hear from you what is holding you back." "There are millions of people living in pain and very few are doing anything about it and instead living in pain for years before seeking treatment," said Ivan Tornos, President and Chief Executive Officer of Zimmer Biomet. "No one is better positioned to ignite this movement to motivate people to terminate their pain more than the Terminator himself. The rapid innovation we are driving in our industry has made it easier and faster to recover from joint replacement surgeries. Now is the time to empower patients to have a voice and a choice in their health journey." Beginning today, people living with joint pain or limited mobility can submit stories about their experience on Schwarzenegger and his team will read the submissions and select community members to be featured in a motivational docuseries. Osteoarthritis, the most common reason for joint replacement, occurs when the cartilage that cushions and protects the ends of your bones gradually wears away, leading to progressive pain and stiffness that makes it difficult to do everyday activities. The Centers for Disease Control estimates nearly 27 million Americans over the age of 65 are impacted by the condition.1 Joint replacement, a surgical procedure where a damaged joint or part of a joint is replaced with an implant, may be recommended by a physician when other treatments are not effective in relieving pain.2 By 2030, an estimated 4 million people in the U.S. will be in need of a joint replacement.3 Visit to share your story, join the community, subscribe for updates, and access the "Find a Doctor" tool to find a qualified physician near you. About Arnold SchwarzeneggerArnold Schwarzenegger is a global icon known for his many accomplishments ranging from world-champion bodybuilder, Hollywood action hero, businessman, environmentalist, philanthropist, best-selling author and public servant. Known for his roles in blockbuster films and as Governor of California from 2003-2011, he most recently has joined Zimmer Biomet as Chief Movement Officer. Follow Schwarzenegger on LinkedIn, Instagram, Facebook and X / Twitter. About Zimmer Biomet Zimmer Biomet is a global medical technology leader with a comprehensive portfolio designed to maximize mobility and improve health. We seamlessly transform the patient experience through our innovative products and suite of integrated digital and robotic technologies that leverage data, data analytics and artificial intelligence. With 90+ years of trusted leadership and proven expertise, Zimmer Biomet is positioned to deliver the highest quality solutions to patients and providers. Our legacy continues to come to life today through our progressive culture of evolution and innovation. For more information about our product portfolio, our operations in 25+ countries and sales in 100+ countries or about joining our team, visit or follow on LinkedIn at or X / Twitter at MediaInvestors Heather Kirsten Sources: View original content: SOURCE Zimmer Biomet Holdings, Inc.
